Search - tctmd.com

Displaying 1 - 20 of 69

Sort: Relevancy | Date

Presentation THT 2026

Pathophysiology of HFrEF in Patients with Enlarged Ventricles — Rationale for Ventricular Reconstruction

Presenter: Eric Jose Velazquez

March 03, 2026

Presentation NY Valves 2025

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

Presenter: Anjali Owens

June 25, 2025

Presentation TCT 2024

Atrial FMR Primer: Epidemiology, Pathophysiology, Imaging Features, and Clinical Presentation

Presenter: Federico Asch

October 29, 2024

Presentation TCT 2024

How Cardiogenic Shock Working Group (CSWG) Registry Findings have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

Presenter: Navin Kapur

October 28, 2024

Presentation TCT 2024

The Critical Care Cardiology Trial Network Shock Registry: How C3TN Findings Have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

Presenter: David Morrow

October 28, 2024

Presentation NY Valves 2024

Natural History, Pathophysiology and Classification of Tricuspid Regurgitation

Presenter: Yan Topilsky

June 07, 2024

Presentation NY Valves 2024

Defining Atrial Functional Mitral Regurgitation: Pathophysiology and Imaging Features

Presenter: Paul A. Grayburn

June 05, 2024

Presentation THT 2024

Insights in the the Role of Exosomes in the Pathophysiology and Treatment of Heart Failure

Presenter: Ke Cheng

March 05, 2024

Presentation THT 2024

Left Atrial Pathophysiology: Why Shunts Should Help

Presenter: Greg Lewis

March 05, 2024

Presentation Miami Valves 2024

Pathophysiology Insights into TEER

Presenter: Nicolas M. Van Mieghem

February 01, 2024

Presentation TCT 2023

LVAD Associated Aortic Regurgitation: Pathophysiology and Treatment With Dedicated TAVR Systems

Presenter: Torsten Vahl

October 25, 2023

Presentation TCT 2023

Pathophysiology, Diagnosis, and Clinical Presentation

Presenter: David Adlam

October 25, 2023

Presentation TCT 2023

TCT 546: Serial OCT documentation of new calcified nodules: Predictors, Pathophysiology, and Clinical outcomes.

Presenter: Yoichiro SUGIZAKI

October 24, 2023

Presentation THT 2023

Deep Dive: The Role of the Heart in Limiting Exercise Tolerance

Presenter: Barry Borlaug

March 21, 2023

Presentation THT 2023

HFpEF: Beyond Pulmonary Capillary Wedge Pressure

Presenter: Satyam Sarma

March 21, 2023

Presentation THT 2023

Lessons Learned from Exercise Studies of LVAD Patients

Presenter: Donna Mancini

March 21, 2023

Presentation THT 2023

What Limits Exercise Tolerance in Heart Failure: The Big Picture

Presenter: Greg Lewis

March 21, 2023

Presentation THT 2023

New Insights Into the Pathophysiology of HFpEF

Presenter: Philipp Lurz

March 20, 2023

Presentation THT 2022

The Underlying Pathophysiology

Presenter: Greg Lewis

February 01, 2022

Presentation TCT 2021

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Presenter: W. H. Wilson Tang

November 06, 2021

Advertisement

Pathophysiology of HFrEF in Patients with Enlarged Ventricles — Rationale for Ventricular Reconstruction

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

Atrial FMR Primer: Epidemiology, Pathophysiology, Imaging Features, and Clinical Presentation

How Cardiogenic Shock Working Group (CSWG) Registry Findings have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

The Critical Care Cardiology Trial Network Shock Registry: How C3TN Findings Have Advanced Understanding of Pathophysiology, Prognosis and Therapeutics

Natural History, Pathophysiology and Classification of Tricuspid Regurgitation

Defining Atrial Functional Mitral Regurgitation: Pathophysiology and Imaging Features

Insights in the the Role of Exosomes in the Pathophysiology and Treatment of Heart Failure

Left Atrial Pathophysiology: Why Shunts Should Help

Pathophysiology Insights into TEER

LVAD Associated Aortic Regurgitation: Pathophysiology and Treatment With Dedicated TAVR Systems

Pathophysiology, Diagnosis, and Clinical Presentation

TCT 546: Serial OCT documentation of new calcified nodules: Predictors, Pathophysiology, and Clinical outcomes.

Deep Dive: The Role of the Heart in Limiting Exercise Tolerance

HFpEF: Beyond Pulmonary Capillary Wedge Pressure

Lessons Learned from Exercise Studies of LVAD Patients

What Limits Exercise Tolerance in Heart Failure: The Big Picture

New Insights Into the Pathophysiology of HFpEF

The Underlying Pathophysiology

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content